Explore

Trendline Trendline
Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding into U.S. Market

Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding into U.S. Market

Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding into U.S. Market
Trendline Trendline
Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding US Market Presence

Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding US Market Presence

Angelini Pharma Acquires Catalyst Pharma for $4.1 Billion, Expanding US Market Presence
Trendline Trendline
Angelini Pharma Expands into U.S. Market with $4.1 Billion Acquisition of Catalyst Pharma

Angelini Pharma Expands into U.S. Market with $4.1 Billion Acquisition of Catalyst Pharma

Angelini Pharma Expands into U.S. Market with $4.1 Billion Acquisition of Catalyst Pharma
Trendline Trendline
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion to Expand in U.S. Rare Disease Market

Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion to Expand in U.S. Rare Disease Market

Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion to Expand in U.S. Rare Disease Market
Trendline Trendline
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1B to Enter U.S. Rare Disease Market

Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1B to Enter U.S. Rare Disease Market

Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1B to Enter U.S. Rare Disease Market
Trendline Trendline
Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth

Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth

Innoviva Reports Strong Q1 2026 Financial Results Amid Strategic Growth
Trendline Trendline
Disney's Streaming and Theme Parks Drive Strong Second Quarter Performance

Disney's Streaming and Theme Parks Drive Strong Second Quarter Performance

Disney's Streaming and Theme Parks Drive Strong Second Quarter Performance
Trendline Trendline
BMW Faces Revenue Decline Amidst China Sales Drop and U.S. Market Challenges

BMW Faces Revenue Decline Amidst China Sales Drop and U.S. Market Challenges

BMW Faces Revenue Decline Amidst China Sales Drop and U.S. Market Challenges
Trendline Trendline
Sarepta Therapeutics Urges Caution in Expectations for Elevidys Recovery Amidst FDA Restrictions

Sarepta Therapeutics Urges Caution in Expectations for Elevidys Recovery Amidst FDA Restrictions

Sarepta Therapeutics Urges Caution in Expectations for Elevidys Recovery Amidst FDA Restrictions
Trendline Trendline
Devon Energy Completes Merger with Coterra, Strengthens Delaware Basin Position

Devon Energy Completes Merger with Coterra, Strengthens Delaware Basin Position

Devon Energy Completes Merger with Coterra, Strengthens Delaware Basin Position
Trendline Trendline
Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD
Trendline Trendline
Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results

Travere Therapeutics Reports Significant Growth in Q1 2026 Financial Results